DPZ Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower HOVR Q1 2026 Earnings WiderThanExpected Loss as Development Continues Stock Surges Over 26 KINS Q1 2026 Earnings EPS Misses Estimates Amid Challenging Underwriting Environment Scilex Holding SCLX Q1 2026 Earnings Reported EPS of 476 Stock Rises Over 6 Amid No Revenue Mineralys Therapeutics MLYS Q1 2026 Earnings Narrowerthanexpected Loss as Clinical Progress Continues Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings Significant EPS Miss Amid PreClinical Stage Operations